Screen Reader Mode Icon
To help us evaluate the program, "Optimizing testing and treatment strategies in the era of precision medicine: NTRK gene fusion and RET alteration cases from the clinic,” please select your responses to the statements below.

Question Title

* 1. Compared to other virtual satellite symposia I have attended over the past year,
I would rate this program as excellent.

Question Title

* 2. The content of the symposium was relevant to my current testing practices
in NSCLC and thyroid cancer.

Question Title

* 3. The symposium increased my understanding of the role of comprehensive
genomic profiling and NGS in evaluating NSCLC and thyroid cancers.

Question Title

* 4. This symposium addressed issues that will help me improve testing for NTRK
gene fusions and RET alterations in NSCLC and thyroid cancers.

Question Title

* 5. After participating in this program, my testing for NTRK gene fusions and RET
alterations will __________.

Question Title

* 6. After participating in this program, I _____ utilize NGS for comprehensive
genomic profiling in NSCLC and thyroid cancer?

© 2021 Bayer. PP-VIT-ALL-0461 08/21
Illumina
Lilly GM-22306
0 of 6 answered
 

T